HealthCap VII L.P. 13D/13G Filings for Aprea Therapeutics, Inc. (APRE)

HealthCap VII L.P. 13D and 13G filings for Aprea Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2022-11-15
5:08 pm
Unchanged		2022-10-2613DAprea Therapeutics, Inc.
APRE		HealthCap VII L.P.118,305
4.500%		0
(Unchanged)		Filing
2022-06-30
4:34 pm
Unchanged		2022-06-3013DAprea Therapeutics, Inc.
APRE		HealthCap VII L.P.118,305
10.100%		0
(Unchanged)		Filing
2021-10-15
4:50 pm
Unchanged		2021-10-1313DAprea Therapeutics, Inc.
APRE		HealthCap VII L.P.118,305
11.200%		0
(Unchanged)		Filing